Regulation of vascular type 1 angiotensin receptors by cytokines

Hiroyuki Sasamura, Yuichi Nakazato, Tomoko Hayashida, Yudai Kitamura, Matsuhiko Hayashi, Takao Saruta

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Although various cytokines are known to be expressed in atherosclerotic lesions, it is not known how these cytokines affect receptors for the peptide hormone angiotensin II (Ang II). We therefore examined the effects of interleukin-1α (220 U/mL [10 ng/mL]), tumor necrosis factor-α (280 U/mL [100 ng/mL]), and interferon gamma (100 U/mL) on Ang II type 1 (AT,) receptors expressed in rat vascular smooth muscle cells. Treatment with interleukin-1α caused a 1.4- to 1.7-fold increase in AT, binding after 24 hours (P<.01) and a 2.3-fold increase in AT1 mRNA (P<.05). Tumor necrosis factor-α and interferon gamma did not cause a significant change in AT1 binding when administered alone but caused a 30% reduction in binding when administered together (P<.05). The maximal decrease in AT1 binding (60%, P<.01) was seen with the combination of interleukin-1α with tumor necrosis factor-α and interferon gamma. Although the upregulation of AT1 by interleukin-1α was unaffected by pretreatment of cells with N-monomethyl-L- arginine or indomethacin, downregulation of AT1 by interleukin-1α combined with tumor necrosis factor-α/interferon gamma was inhibited by N-monomethyl- L-arginine (P<.01). Interleukin-1α treatment enhanced Ang II-induced [3H]uridine incorporation, whereas treatment with interleukin-1α combined with tumor necrosis factor-α/interferon gamma attenuated Ang II-induced [3H]uridine and [3H]leucine incorporation. These results demonstrate that interleukin-1α upregulates AT1 receptors and enhances Ang II-stimulated hypertrophic responses. However, a combination of interleukin-1α with tumor necrosis factor-α and interferon gamma downregulates AT1 receptors by a nitric oxide-dependent mechanism and reduces Ang 11-stimulated trophic responses in vascular smooth muscle cells.

Original languageEnglish
Pages (from-to)35-41
Number of pages7
JournalHypertension
Volume30
Issue number1
Publication statusPublished - 1997 Jul

Fingerprint

Angiotensin Type 1 Receptor
Interleukin-1
Blood Vessels
Cytokines
Interferon-gamma
Tumor Necrosis Factor-alpha
Angiotensin II
Uridine
Vascular Smooth Muscle
Smooth Muscle Myocytes
Arginine
Up-Regulation
Down-Regulation
Cytokine Receptors
Angiotensin Receptors
Peptide Hormones
Leucine
Indomethacin
Messenger RNA

Keywords

  • Angiotensin
  • Cytokines
  • Interferons
  • Interleukin-1
  • Receptors
  • Tumor necrosis factor

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Sasamura, H., Nakazato, Y., Hayashida, T., Kitamura, Y., Hayashi, M., & Saruta, T. (1997). Regulation of vascular type 1 angiotensin receptors by cytokines. Hypertension, 30(1), 35-41.

Regulation of vascular type 1 angiotensin receptors by cytokines. / Sasamura, Hiroyuki; Nakazato, Yuichi; Hayashida, Tomoko; Kitamura, Yudai; Hayashi, Matsuhiko; Saruta, Takao.

In: Hypertension, Vol. 30, No. 1, 07.1997, p. 35-41.

Research output: Contribution to journalArticle

Sasamura, H, Nakazato, Y, Hayashida, T, Kitamura, Y, Hayashi, M & Saruta, T 1997, 'Regulation of vascular type 1 angiotensin receptors by cytokines', Hypertension, vol. 30, no. 1, pp. 35-41.
Sasamura H, Nakazato Y, Hayashida T, Kitamura Y, Hayashi M, Saruta T. Regulation of vascular type 1 angiotensin receptors by cytokines. Hypertension. 1997 Jul;30(1):35-41.
Sasamura, Hiroyuki ; Nakazato, Yuichi ; Hayashida, Tomoko ; Kitamura, Yudai ; Hayashi, Matsuhiko ; Saruta, Takao. / Regulation of vascular type 1 angiotensin receptors by cytokines. In: Hypertension. 1997 ; Vol. 30, No. 1. pp. 35-41.
@article{ce8b76bf18b9475980254636d069ca0e,
title = "Regulation of vascular type 1 angiotensin receptors by cytokines",
abstract = "Although various cytokines are known to be expressed in atherosclerotic lesions, it is not known how these cytokines affect receptors for the peptide hormone angiotensin II (Ang II). We therefore examined the effects of interleukin-1α (220 U/mL [10 ng/mL]), tumor necrosis factor-α (280 U/mL [100 ng/mL]), and interferon gamma (100 U/mL) on Ang II type 1 (AT,) receptors expressed in rat vascular smooth muscle cells. Treatment with interleukin-1α caused a 1.4- to 1.7-fold increase in AT, binding after 24 hours (P<.01) and a 2.3-fold increase in AT1 mRNA (P<.05). Tumor necrosis factor-α and interferon gamma did not cause a significant change in AT1 binding when administered alone but caused a 30{\%} reduction in binding when administered together (P<.05). The maximal decrease in AT1 binding (60{\%}, P<.01) was seen with the combination of interleukin-1α with tumor necrosis factor-α and interferon gamma. Although the upregulation of AT1 by interleukin-1α was unaffected by pretreatment of cells with N-monomethyl-L- arginine or indomethacin, downregulation of AT1 by interleukin-1α combined with tumor necrosis factor-α/interferon gamma was inhibited by N-monomethyl- L-arginine (P<.01). Interleukin-1α treatment enhanced Ang II-induced [3H]uridine incorporation, whereas treatment with interleukin-1α combined with tumor necrosis factor-α/interferon gamma attenuated Ang II-induced [3H]uridine and [3H]leucine incorporation. These results demonstrate that interleukin-1α upregulates AT1 receptors and enhances Ang II-stimulated hypertrophic responses. However, a combination of interleukin-1α with tumor necrosis factor-α and interferon gamma downregulates AT1 receptors by a nitric oxide-dependent mechanism and reduces Ang 11-stimulated trophic responses in vascular smooth muscle cells.",
keywords = "Angiotensin, Cytokines, Interferons, Interleukin-1, Receptors, Tumor necrosis factor",
author = "Hiroyuki Sasamura and Yuichi Nakazato and Tomoko Hayashida and Yudai Kitamura and Matsuhiko Hayashi and Takao Saruta",
year = "1997",
month = "7",
language = "English",
volume = "30",
pages = "35--41",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Regulation of vascular type 1 angiotensin receptors by cytokines

AU - Sasamura, Hiroyuki

AU - Nakazato, Yuichi

AU - Hayashida, Tomoko

AU - Kitamura, Yudai

AU - Hayashi, Matsuhiko

AU - Saruta, Takao

PY - 1997/7

Y1 - 1997/7

N2 - Although various cytokines are known to be expressed in atherosclerotic lesions, it is not known how these cytokines affect receptors for the peptide hormone angiotensin II (Ang II). We therefore examined the effects of interleukin-1α (220 U/mL [10 ng/mL]), tumor necrosis factor-α (280 U/mL [100 ng/mL]), and interferon gamma (100 U/mL) on Ang II type 1 (AT,) receptors expressed in rat vascular smooth muscle cells. Treatment with interleukin-1α caused a 1.4- to 1.7-fold increase in AT, binding after 24 hours (P<.01) and a 2.3-fold increase in AT1 mRNA (P<.05). Tumor necrosis factor-α and interferon gamma did not cause a significant change in AT1 binding when administered alone but caused a 30% reduction in binding when administered together (P<.05). The maximal decrease in AT1 binding (60%, P<.01) was seen with the combination of interleukin-1α with tumor necrosis factor-α and interferon gamma. Although the upregulation of AT1 by interleukin-1α was unaffected by pretreatment of cells with N-monomethyl-L- arginine or indomethacin, downregulation of AT1 by interleukin-1α combined with tumor necrosis factor-α/interferon gamma was inhibited by N-monomethyl- L-arginine (P<.01). Interleukin-1α treatment enhanced Ang II-induced [3H]uridine incorporation, whereas treatment with interleukin-1α combined with tumor necrosis factor-α/interferon gamma attenuated Ang II-induced [3H]uridine and [3H]leucine incorporation. These results demonstrate that interleukin-1α upregulates AT1 receptors and enhances Ang II-stimulated hypertrophic responses. However, a combination of interleukin-1α with tumor necrosis factor-α and interferon gamma downregulates AT1 receptors by a nitric oxide-dependent mechanism and reduces Ang 11-stimulated trophic responses in vascular smooth muscle cells.

AB - Although various cytokines are known to be expressed in atherosclerotic lesions, it is not known how these cytokines affect receptors for the peptide hormone angiotensin II (Ang II). We therefore examined the effects of interleukin-1α (220 U/mL [10 ng/mL]), tumor necrosis factor-α (280 U/mL [100 ng/mL]), and interferon gamma (100 U/mL) on Ang II type 1 (AT,) receptors expressed in rat vascular smooth muscle cells. Treatment with interleukin-1α caused a 1.4- to 1.7-fold increase in AT, binding after 24 hours (P<.01) and a 2.3-fold increase in AT1 mRNA (P<.05). Tumor necrosis factor-α and interferon gamma did not cause a significant change in AT1 binding when administered alone but caused a 30% reduction in binding when administered together (P<.05). The maximal decrease in AT1 binding (60%, P<.01) was seen with the combination of interleukin-1α with tumor necrosis factor-α and interferon gamma. Although the upregulation of AT1 by interleukin-1α was unaffected by pretreatment of cells with N-monomethyl-L- arginine or indomethacin, downregulation of AT1 by interleukin-1α combined with tumor necrosis factor-α/interferon gamma was inhibited by N-monomethyl- L-arginine (P<.01). Interleukin-1α treatment enhanced Ang II-induced [3H]uridine incorporation, whereas treatment with interleukin-1α combined with tumor necrosis factor-α/interferon gamma attenuated Ang II-induced [3H]uridine and [3H]leucine incorporation. These results demonstrate that interleukin-1α upregulates AT1 receptors and enhances Ang II-stimulated hypertrophic responses. However, a combination of interleukin-1α with tumor necrosis factor-α and interferon gamma downregulates AT1 receptors by a nitric oxide-dependent mechanism and reduces Ang 11-stimulated trophic responses in vascular smooth muscle cells.

KW - Angiotensin

KW - Cytokines

KW - Interferons

KW - Interleukin-1

KW - Receptors

KW - Tumor necrosis factor

UR - http://www.scopus.com/inward/record.url?scp=0030849135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030849135&partnerID=8YFLogxK

M3 - Article

C2 - 9231818

AN - SCOPUS:0030849135

VL - 30

SP - 35

EP - 41

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 1

ER -